Pharmaceutical

‘The drug bust paradox’: Study shows opioid deaths doub...

Why did you overdose today, of all days? This question inspired a novel study ab...

STAT+: Sanders wants NIH to adopt ‘reasonable pricing’ ...

Sen. Bernie Sanders wants the NIH to adopt "reasonable pricing" protocols for dr...

Teens seeking addiction care unlikely to be offered sta...

“It is tragic to see that young people with opioid use disorder are unable to ac...

STAT+: Moving past regulatory obstacles, Protagonist Th...

Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal tria...

STAT+: Pharmalittle: Exec nominated to Biogen board is ...

Biogen said that its longtime and polarizing director Alex Denner would step dow...

STAT+: Biotech executive nominated to Biogen board is m...

Biotech executive nominated to Biogen board is mother of director's child, recor...

Suicide hotlines promise anonymity. Dozens of their web...

Suicide hotlines promise anonymity. Dozens of their websites send sensitive data...

EHA 2023: Kura Oncology’s menin inhibitor ziftomenib sh...

Kura faces competition in the menin inhibitor market as the therapy is being dev...

Snap Spanish elections throw health reimbursement refor...

Two broad health reform initiatives are affected by the election.

US FDA approves Neobiosis’ IND for post-Covid syndrome ...

ViXome showed potent immunomodulatory and pro-reparative effects in pre-clinical...

FDA accepts AstraZeneca’s NDA for breast cancer combina...

The NDA submission was based on the findings of the CAPItello-291 Phase III trial.

Beacon Therapeutics enters gene therapy arena with $120...

Syncona launches its third gene therapy company to stake a claim in the ophthalm...

FDA gives Ferring go-ahead for Adstiladrin gene therapy...

Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...

USPTO issues notice of allowance for Windtree’s SERCA2A...

The activators might represent both an outpatient, oral therapy for chronic hear...

US FDA approves Ironwood Pharmaceuticals’ LINZESS

The FDA approval was based on the findings obtained from a double-blind multi-ce...

Idorsia introduces Quviviq in Switzerland for chronic i...

The recommended dose of Quviviq is one 50mg tablet to be taken orally each night.